Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pi­based therapy in relapsed/refractory multiple myeloma.

Abe, Yu; Sasaki, Makoto; Takezako, Naoki; Ito, Shigeki; Suzuki, Kazuhito; Handa, Hiroshi; Chou, Takaaki; Yoshida, Takahiro; Mori, Ikuo; Shinozaki, Tomohiro; Suzuki, Kenshi

Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pibased therapy in relapsed/refractory multiple myeloma.

Abe, Yu; Sasaki, Makoto; Takezako, Naoki; Ito, Shigeki; Suzuki, Kazuhito; Handa, Hiroshi; Chou, Takaaki; Yoshida, Takahiro; Mori, Ikuo; Shinozaki, Tomohiro; Suzuki, Kenshi.

Afiliação

Abe Y; Division of Haematology, Japanese Red Cross Medical Centre, 4 Chome-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan.
Sasaki M; Division of Haematology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Takezako N; Division of Haematology, Japan Association for Development of Community Medicine, Nerima Hikarigaoka Hospital, Tokyo, Japan.
Ito S; Division of Haematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan.
Suzuki K; Division of Clinical Oncology and Haematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan.
Handa H; Department of Haematology, Gunma University Graduate School of Medicine, Gunma, Japan.
Chou T; Niigata Kenshin Plaza, General Incorporated Foundation, Health Medicine Prevention Association, Niigata, Japan.
Yoshida T; Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Mori I; Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Shinozaki T; Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
Suzuki K; Division of Haematology, Japanese Red Cross Medical Centre, 4 Chome-1-22 Hiroo, Shibuya City, Tokyo, 150-8935, Japan. ken-suzuki@mtb.biglobe.ne.jp.

Ann Hematol ; 102(9): 2505, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37432416

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google